Acute hepatitis caused by a natural lipid-lowering product: When “alternative” medicine is no “alternative” at all

Institute of Internal Medicine, Catholic University of Rome, 8 Largo A. Gemelli, 00168 Rome, Italy.
Journal of Hepatology (Impact Factor: 11.34). 04/2009; 50(6):1273-7. DOI: 10.1016/j.jhep.2009.02.021
Source: PubMed


The general public's growing mistrust of the pharmaceutical industry and its perception of the lack of adverse effects of "natural" therapy have lead to the increasing use of "alternative drugs" for hypercholesterolemia.
A sixty-three year old woman presented with severe hypertransaminasemia that had developed progressively over a few weeks. For six months she had been taking Equisterol, an over-the-counter lipid-lowering product containing guggulsterol and red yeast rice extract. The product had been prescribed for hypercholesterolemia because the patient had developed hepatotoxicity while on lovastatin.
Liver biopsy revealed severe lobular necroinflammatory changes with an eosinophilic infiltrate. The episode was regarded as an adverse drug reaction after exclusion of other possible causes of acute liver disease and the prompt normalization of liver function tests after Equisterol had been discontinued. Red yeast rice extract's cholesterol-lowering properties are largely due to fungal metabolites known as monacolins, one of which--monacolin K--is identical to lovastatin.
The choice of an alternative medicine approach in this case subjected the patient to "re-challenge" with the official medicine agent that had previously caused mild hepatotoxicity. Physicians should keep in mind that "alternative" medicine is not always the safest alternative and sometimes it is not even "alternative."

Download full-text


Available from: Luca Miele, Oct 05, 2015
28 Reads
  • Source
    • "Nearly two-thirds of antihyperlipidemic activity of MFP is associated with monacolins as natural statins [4]. Monacolins inhibit 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG- CoA) reductase as converter of HMG-CoA to mevalonate in initial stage of cholesterol biosynthesis pathway. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hypercholesterolemia is one of the most common chronic diseases in human. Along with chemical therapy traditional medication is used as hypocholesterolemic remedy, however, with unfavorable side effects. Recently, Monascus fermented product (MFP) has become a popular hypocholesterolemic natural supplement. In the present study, the hypocholesterolemic activity of Monascus purpureus FTC5391 fermented product ethanolic extract (MFPe) was investigated in hypercholesterolemic rats. Results showed that MFPe not only reduced the serum total cholesterol (TC), LDL-C, TG concentration, and TC/HDL-C ratio but also increased the HDL-C. Further, solid phase extraction (SPE) was carried out to obtain the hypocholesterolemic bioactive fraction. The high polar fraction of SPE increased the HDL-C (42%) and decreased the TC (53.3%), LDL-C (47%), and TG (50.7%) levels as well as TC/HDL-C ratio (69.1%) in serum. The GC-MS results of the active fraction revealed two main compounds, isosorbide and erythritol, which act as coronary vasodilator compounds.
    The Scientific World Journal 02/2014; 2014(2):252647. DOI:10.1155/2014/252647 · 1.73 Impact Factor
  • European Journal of Obstetrics & Gynecology and Reproductive Biology 06/1999; 84(1):1-3. DOI:10.1016/S0301-2115(98)00257-7 · 1.70 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hyperlipidemia is prevalent and is highly associated with coronary heart disease. Some patients are reluctant or opt not to take lipid-lowering prescription medications for fear of adverse drug reactions. There are currently few well-designed randomized controlled trials showing the possibility of reducing cholesterol using red yeast rice. Meanwhile, adverse effects have also been reported. A 64-year-old Asian man was diagnosed with hyperlipidemia despite a healthy lifestyle. In addition to diet changes, the patient used red yeast rice and succeeded in lowering his level of serum lipids. Based on this case and a review of current literature, in addition to therapeutic lifestyle change, red yeast rice may be a useful alternative treatment for primary hyperlipidemia in patients with low cardiac risk and who refuse to take any lipid-lowering prescription medication or who maybe be statin intolerant.However, primary care physicians must be aware of the potential side effects of taking red yeast rice.
    Journal of Medical Case Reports 01/2010; 4:4. DOI:10.1186/1752-1947-4-4
Show more